A Rodent Model of Traumatic Stress Induces Lasting Sleep and Quantitative Electroencephalographic Disturbances
Overview
Authors
Affiliations
Hyperarousal and sleep disturbances are common, debilitating symptoms of post-traumatic stress disorder (PTSD). PTSD patients also exhibit abnormalities in quantitative electroencephalography (qEEG) power spectra during wake as well as rapid eye movement (REM) and non-REM (NREM) sleep. Selective serotonin reuptake inhibitors (SSRIs), the first-line pharmacological treatment for PTSD, provide modest remediation of the hyperarousal symptoms in PTSD patients, but have little to no effect on the sleep-wake architecture deficits. Development of novel therapeutics for these sleep-wake architecture deficits is limited by a lack of relevant animal models. Thus, the present study investigated whether single prolonged stress (SPS), a rodent model of traumatic stress, induces PTSD-like sleep-wake and qEEG spectral power abnormalities that correlate with changes in central serotonin (5-HT) and neuropeptide Y (NPY) signaling in rats. Rats were implanted with telemetric recording devices to continuously measure EEG before and after SPS treatment. A second cohort of rats was used to measure SPS-induced changes in plasma corticosterone, 5-HT utilization, and NPY expression in brain regions that comprise the neural fear circuitry. SPS caused sustained dysregulation of NREM and REM sleep, accompanied by state-dependent alterations in qEEG power spectra indicative of cortical hyperarousal. These changes corresponded with acute induction of the corticosterone receptor co-chaperone FK506-binding protein 51 and delayed reductions in 5-HT utilization and NPY expression in the amygdala. SPS represents a preclinical model of PTSD-related sleep-wake and qEEG disturbances with underlying alterations in neurotransmitter systems known to modulate both sleep-wake architecture and the neural fear circuitry.
Insomnia-related rodent models in drug discovery.
Chen Z, Liu Y, Zhou J, Chen G, Liu C, Qu W Acta Pharmacol Sin. 2024; 45(9):1777-1792.
PMID: 38671193 PMC: 11335876. DOI: 10.1038/s41401-024-01269-w.
Grafe L, Miller K, Ross R, Bhatnagar S Neurobiol Stress. 2023; 28:100588.
PMID: 38075023 PMC: 10709081. DOI: 10.1016/j.ynstr.2023.100588.
Lo Y, Yi P, Hsiao Y, Lee T, Chang F Commun Biol. 2023; 6(1):716.
PMID: 37438582 PMC: 10338557. DOI: 10.1038/s42003-023-05090-9.
Teal L, Ingram S, Bubser M, McClure E, Jones C Adv Neurobiol. 2023; 30:37-99.
PMID: 36928846 DOI: 10.1007/978-3-031-21054-9_3.
Vanderheyden W, Lefton M, Flores C, Owada Y, Gerstner J Neuroglia. 2023; 3(2):73-83.
PMID: 36909794 PMC: 10001429. DOI: 10.3390/neuroglia3020005.